APA (7th ed.) Citation

Song, Y., Wang, Z., Wang, N., Xie, X., Zhu, T., & Wang, Y. A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database. Nature Portfolio.

Chicago Style (17th ed.) Citation

Song, Yongfu, Zhuang Wang, Na Wang, Xiaofei Xie, Tieshi Zhu, and Yongji Wang. A Real-world Pharmacovigilance Study of Omalizumab Using Disproportionality Analysis in the FDA Adverse Drug Events Reporting System Database. Nature Portfolio.

MLA (9th ed.) Citation

Song, Yongfu, et al. A Real-world Pharmacovigilance Study of Omalizumab Using Disproportionality Analysis in the FDA Adverse Drug Events Reporting System Database. Nature Portfolio.